Last reviewed · How we verify

IFN-alpha — Competitive Intelligence Brief

IFN-alpha (IFN-alpha) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Interferon. Area: Oncology.

phase 2 Interferon IFN-alpha receptor Oncology Small molecule Live · refreshed every 30 min

Target snapshot

IFN-alpha (IFN-alpha) — Active Biotech AB. Interferes with viral replication by binding to the cell surface receptor for the virus.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
IFN-alpha TARGET IFN-alpha Active Biotech AB phase 2 Interferon IFN-alpha receptor
Besremi ROPEGINTERFERON ALFA-2B Pharma Essentia Corporation marketed Interferon alfa-2b [EPC] Interferon alpha/beta receptor 2021-01-01
Saphnelo ANIFROLUMAB AstraZeneca marketed Type I Interferon Receptor Antagonist [EPC] Interferon alpha/beta receptor 1 2021-01-01
Gamifant EMAPALUMAB Novimmune S.A. marketed Interferon gamma Blocker [EPC] Interferon gamma 2018-01-01
Plegridy PEGINTERFERON BETA-1A Biogen Idec Inc marketed Interferon beta [EPC] Interferon alpha/beta receptor 2014-01-01
Avonex INTERFERON BETA-1A Biogen marketed Interferon beta [EPC] Interferon alpha/beta receptor 1996-01-01
Betaseron INTERFERON BETA-1B Bayer Healthcare Pharms marketed Interferon beta Interferon alpha/beta receptor 1993-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Interferon class)

  1. EMD Serono · 3 drugs in this class
  2. Cinnagen · 2 drugs in this class
  3. Tanabe Pharma Corporation · 2 drugs in this class
  4. Biogen · 1 drug in this class
  5. Celgene · 1 drug in this class
  6. EMD Serono Research & Development Institute, Inc. · 1 drug in this class
  7. Case Comprehensive Cancer Center · 1 drug in this class
  8. Hoffmann-La Roche · 1 drug in this class
  9. Human Genome Sciences Inc. · 1 drug in this class
  10. Bayer · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). IFN-alpha — Competitive Intelligence Brief. https://druglandscape.com/ci/ifn-alpha. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: